# China NMPA Drug Inspection - Zhuhai Federal Pharmaceutical Co., Ltd. - Amoxicillin sodium clavulanate potassium (5:1)

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/zhuhai-federal-pharmaceutical-co-ltd/0812f5e8-d0b6-4c08-a2f2-7562f67d36a8/
Source feed: China

> China NMPA drug inspection for Zhuhai Federal Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Amoxicillin sodium clavulanate potassium (5:1). 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 5, 2021)
- Company Name: Zhuhai Federal Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Amoxicillin sodium clavulanate potassium (5:1)
- Inspection Finding: Compliant with drug standards

Company: https://www.globalkeysolutions.net/companies/zhuhai-federal-pharmaceutical-co-ltd/bb4825c4-f115-47da-9153-e81b46bcc131/